Kiener Peter A
SEC insider (Form 3/4/5 filer). CIK 0001328146. Director at Cue Biopharma, Inc. (CUE) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 2, 2026. Located in BOSTON, MA.
Companies Kiener Peter A has filed insider reports for
- Cue Biopharma, Inc. (CUE): Director
- LAVA Therapeutics NV (LVTX): Director
Kiener Peter A
CIK: 0001328146
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 2, 2026CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
24.4K shares- - Nov 13, 2025LVTX
LAVA Therapeutics NV
DispositionDirectShare Options (Right to Buy)
33.4K shares- - Feb 13, 2025LVTX
LAVA Therapeutics NV
AwardDirectCommon Shares (Right to Buy)
33.4K shares- - Jan 2, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
24.4K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 2, 2026 |  CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 24,400 | - | - | Direct |
| Nov 13, 2025 |  LVTX LAVA Therapeutics NV | Disposition Share Options (Right to Buy) | 33,390 | - | - | Direct |
| Feb 13, 2025 | LVTX LAVA Therapeutics NV | Award Common Shares (Right to Buy) | 33,390 | - | - | Direct |
| Jan 2, 2025 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 24,400 | - | - | Direct |
1-4 of 4 transactions